Back to News
Market Impact: 0.46

Stocks making the biggest moves midday: UnitedHealth, Pitney Bowes, Apple, Amazon & more

VMIPBIOFGRHIUNHMMMAMZNAAPLALKGESTLDDHITSCODGX
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesCapital Returns (Dividends / Buybacks)Artificial IntelligenceManagement & GovernanceHousing & Real EstateTransportation & LogisticsHealthcare & BiotechBanking & LiquidityConsumer Demand & Retail
Stocks making the biggest moves midday: UnitedHealth, Pitney Bowes, Apple, Amazon & more

The midday tape was driven by a cluster of earnings and guidance updates, led by Valmont Industries (+12%) on a Q1 beat and a higher low-end full-year EPS outlook, and UnitedHealth (+9%) on adjusted EPS of $7.23 and revenue of $11.72B above estimates. Other notable movers included Pitney Bowes (+8%) on preliminary Q1 revenue of $477M, D.R. Horton (+7.2%) on EPS of $2.24, and Quest Diagnostics (+5.2%) on an earnings/revenue beat, while 3M (-2%), Alaska Air Group (-1%), GE Aerospace (-6%), and Tractor Supply (-9%) fell on weaker guidance or misses. Amazon rose 1.8% after agreeing to invest up to $25B in Anthropic, highlighting the AI infrastructure theme, while Apple slipped less than 2% on CEO transition news.

Analysis

The tape is rewarding clean beats with explicit capital-return or guidance upside, but the real signal is that investors are paying up for earnings visibility in a choppy macro while punishing any hint of cyclical uncertainty. The strongest second-order beneficiaries are the suppliers and peers tied to regulated infrastructure, healthcare utilization, and housing-related demand: VMI’s utility strength is a read-through for grid capex, UNH’s raise reinforces managed-care pricing power, and DHI’s outperformance suggests homebuilding demand is still holding despite mortgage-rate friction. By contrast, TSCO and ALK show the market is still willing to sell names where demand is intact but forward margins or cost inputs are harder to pin down. The sharp move in GE is a warning that in industrials, a miss in a single operational metric can overwhelm a headline earnings beat because the market is repricing the medium-term trajectory, not the quarter. That matters for STLD too: modestly positive earnings reactions in metals usually fade unless end-demand and pricing inflect together. On the defensive side, DGX looks like a steadier beneficiary than the headline move implies; if healthcare utilization remains elevated, diagnostic volumes should compound with less cyclicality than the broad market is discounting. The contrarian setup is that the biggest upside gaps may be in names where low expectations and capital returns are doing the heavy lifting, not the headline beat itself. OFG and PBI are the type of small-cap re-rating candidates that can continue another 10-15% if buybacks/dividend growth are sustained, while UNH’s guidance raise can anchor the managed-care group for weeks if no regulatory headline emerges. The main risk is that this is a one-day valuation reset rather than a durable trend: if rates back up or guidance quality weakens, the market will quickly rotate from ‘beat and raise’ into ‘show me’ mode within the next 1-3 reporting cycles.